Radiopharmaceuticals/Nuclear Medicine Market Size, Share & Growth 2029 - PowerPoint PPT Presentation

About This Presentation
Title:

Radiopharmaceuticals/Nuclear Medicine Market Size, Share & Growth 2029

Description:

The global Radiopharmaceuticals/Nuclear Medicine Market was valued at US$ 5605 Million in 2022 and is anticipated to grow at US$ 9327 Million by 2029 recording a CAGR of 9.3% during the forecast period 2023-2029. Request sample report at – PowerPoint PPT presentation

Number of Views:7
Slides: 6
Provided by: MathurReshma
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Radiopharmaceuticals/Nuclear Medicine Market Size, Share & Growth 2029


1
Radiopharmaceuticals/Nuclear Medicine Market
(2023-2029)
2
Market Overview
The global Radiopharmaceuticals/Nuclear Medicine
Market was valued at US 5605 Million in 2022 and
is anticipated to grow at US 9327 Million by
2029 recording a CAGR of 9.3 during the forecast
period 2023-2029. The Radiopharmaceuticals/Nuclea
r Medicine Market research report also provides
opportunities for business owners to exploit
through the use of relevant approaches. The
studys prospects assist stakeholders and report
purchasers in properly planning their investments
and augmenting their profits. The report
provides a quantitative analysis of the market
segments, trends, estimations, and dynamics of
the Radiopharmaceuticals/Nuclear Medicine Market
analysis from 2023 to 2029 to identify the
prevailing market opportunities. In addition,
the report discusses the implications of
COVID-19, including the industry's initial
response and strategies for ensuring business
continuity in the coming years. View Detailed
Report Description
3
Market Segments
  • The Radiopharmaceuticals/Nuclear Medicine Market
    has been fragmented based on
  • By Product Type Diagnostic Radiopharmaceuticals
    (SPECT Radiopharmaceuticals and PET
    Radiopharmaceuticals) and Therapeutic
    Radiopharmaceuticals (Beta Emitters, Alpha
    emitters, Brachytherapy, and Others)
  • By Application oncology, neurological disorders,
    cardiovascular disease, thyroid, and Others
  • By Route of Administration oral, inhalation, and
    Parenteral
  • By End User Hospitals, Clinics, Diagnostic
    Centers, and Research Institutes
  • Request Sample Report

4
Key Players
  • Some of the major key players in the
    Radiopharmaceuticals/Nuclear Medicine Marketare
  • Advanced Accelerator Applications
  • Bayer
  • Bracco Imaging
  • Cardinal Health
  • Eli Lilly and Co.
  • GE Healthcare
  • IBA Molecular Imaging
  • Jubilant Life Sciences Ltd
  • Lantheus Medical Imaging
  • Request Sample Report

5
Europe Office Precision Business Insights, Kemp
House, 152 160 City Road, London EC1V
2NX Asia-Pacific Office Precision Business
Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB
Colony, Hyderabad 500072 Email sales_at_precisionb
usinessinsights.com Toll-Free 1-866-598-1553
Write a Comment
User Comments (0)
About PowerShow.com